Industry Strength Score
8/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
PENTIXAPHARM HOLDING AG (PTP.DE) Stock Price & Overview
FRA:PTP • DE000A40AEG0
Current stock price
2.02 EUR
-0.05 (-2.42%)
Last:
The current stock price of PTP.DE is 2.02 EUR. Today PTP.DE is down by -2.42%. In the past month the price increased by 11.48%. In the past year, price decreased by -31.76%.
PTP.DE Key Statistics
52-Week Range1.3 - 3.7
Current PTP.DE stock price positioned within its 52-week range.
1-Month Range1.822 - 2.17
Current PTP.DE stock price positioned within its 1-month range.
- Market Cap
- 50.096M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.86
- Dividend Yield
- N/A
PTP.DE Stock Performance
Today
-2.42%
1 Week
-0.98%
1 Month
+11.48%
3 Months
+6.65%
Longer-term
6 Months +31.17%
1 Year -31.76%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
PTP.DE Stock Chart
PTP.DE Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to PTP.DE. When comparing the yearly performance of all stocks, PTP.DE is a bad performer in the overall market: 87.13% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
PTP.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PTP.DE. PTP.DE has a great financial health rating, but its profitability evaluates not so good.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
PTP.DE Earnings
Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ3 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
PTP.DE Forecast & Estimates
5 analysts have analysed PTP.DE and the average price target is 11.95 EUR. This implies a price increase of 491.8% is expected in the next year compared to the current price of 2.02.
Analysts
Analysts80
Price Target11.95 (491.58%)
EPS Next YN/A
Revenue Next YearN/A
PTP.DE Financial Highlights
Over the last trailing twelve months PTP.DE reported a non-GAAP Earnings per Share(EPS) of -0.86.
Income Statements
Revenue(TTM)6.93M
Net Income(TTM)-25.48M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -59.32% | ||
| ROE | -69.4% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%-14325%
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
PTP.DE Ownership
Ownership
Inst Owners4.34%
Shares24.80M
Float13.68M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
PTP.DE Industry Overview
PTP.DE operates in the Health Care Supplies sub-industry within the Health Care sector. This group contains 8 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
9/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
9%
Outperformed 9% of sub-industries
3 Month Rank
11%
Outperformed 11% of sub-industries
6 Month Rank
7%
Outperformed 7% of sub-industries
Industry Fundamentals & Breadth
- Members
- 8
- New Highs
- 0%
- New Lows
- 37.5%
- Average ROE
- 6%
- Average Profit Margin
- 8.1%
- Average Operating Margin
- 11.9%
- Average P/E
- 26.4
- Average Fwd P/E
- 23.6
- Average Debt/Equity
- 0.2
PTP.DE Competitors/Peers
The largest stocks on the EU markets in the "Health Care Supplies" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1EL | ESSILORLUXOTTICA | 23.77 | 84.249B | ||
| EL | ESSILORLUXOTTICA | 23.69 | 83.971B | ||
| ESL | ESSILORLUXOTTICA | 23.5 | 83.3B | ||
| CVX | CARVOLIX SA | N/A | 167.649M | ||
| GBT | GUERBET | N/A | 146.624M | ||
| ALCJ | CROSSJECT | 7.11 | 101.083M | ||
| SVS | SVAS BIOSANA SPA | 5.99 | 49.504M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About PTP.DE
Company Profile
Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company is headquartered in Berlin, Berlin and currently employs 64 full-time employees. The company went IPO on 2024-10-03. The firm focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. The company is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.
Company Info
IPO: 2024-10-03
PENTIXAPHARM HOLDING AG
Robert-Roessle-Strasse 10
Berlin BERLIN DE
Employees: 64
Phone: 493094893220
PENTIXAPHARM HOLDING AG / PTP.DE FAQ
What does PENTIXAPHARM HOLDING AG do?
Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company is headquartered in Berlin, Berlin and currently employs 64 full-time employees. The company went IPO on 2024-10-03. The firm focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. The company is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.
What is the stock price of PENTIXAPHARM HOLDING AG today?
The current stock price of PTP.DE is 2.02 EUR. The price decreased by -2.42% in the last trading session.
What is the dividend status of PENTIXAPHARM HOLDING AG?
PTP.DE does not pay a dividend.
What is the ChartMill rating of PENTIXAPHARM HOLDING AG stock?
PTP.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for PTP stock?
PENTIXAPHARM HOLDING AG (PTP.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.86).
How many employees does PENTIXAPHARM HOLDING AG have?
PENTIXAPHARM HOLDING AG (PTP.DE) currently has 64 employees.
Can you provide the ownership details for PTP stock?
You can find the ownership structure of PENTIXAPHARM HOLDING AG (PTP.DE) on the Ownership tab.